Severe alcoholic hepatitis: An effective combination of two treatments
November 10, 2011 in Diseases, Conditions, SyndromesA French multi-center study has shown that a treatment combining an antioxidant with an anti-inflammatory was effective on 174 patients suffering from severe alcoholic hepatitis. The study was coordinated by the Hepato-Gastroenterology department at the Amiens University Hospital Centre and the "Early exposure to alcohol and dependency vulnerability," INSERM 24 research team. Their findings were published in the New England Journal of Medicine on Nov. 10 2011.
Acute alcoholic hepatitis is one of the most serious forms of alcoholic liver disease, affecting individuals with chronic excessive alcohol consumption, which generally equates to more than 50 grams of alcohol per day (roughly five drinks), over a period of more than three to six months. The disease is characterized by liver failure (hepatic insufficiency) and acute jaundice (icterus), which may induce a coma through liver failure (hepatic encephalopathy) and an ensuing death rate of between 40-45% within the first six months. Conventional treatment involves stopping alcohol consumption (alcohol abstinence) and administering cortisone (corticosteroid therapy over a one-month period) to fight the highly inflammatory nature of the disease. Despite this treatment, 30-35% of patients with acute alcoholic hepatitis still die within a six month period, since the cortisone-based treatment remains insufficient.
Given the given the frequent deficiency in the antioxidant capacity of the alcoholic liver (described above), combined with chronic inflammation associated with the disease, the aim of the study coordinated by Professor Nguyen-Khas (Amiens University Hospital Centre and the Inserm research team) was to combine an antioxidant treatment with the conventional anti-inflammatory treatment. The results show an improved survival rate for patients suffering from acute alcoholic hepatitis who were given both medication types, with significantly less deaths within one month of treatment compared to the group who received the cortisone- only treatment. Tolerance levels to the treatment were good. The new, very low-cost medicine (N-acetylcysteine) is a molecule that has long been used in the treatment of hepatitis caused by drugs such as paracetamol, or mucolytic to fluidify bronchial secretion.
These results improve the prognosis for severe alcoholic hepatitis patients.
More information: "Glucocorticoids plus N-acetylcysteine in Severe Alcoholic Hepatitis". Nguyen-Khac and coll. The New England Journal of Medicine 2011; 365 10 November 2011.
Journal reference:
New England Journal of Medicine
Provided by INSERM (Institut national de la santé et de la recherche médicale)
-
Mayo Clinic seeks new therapies for alcoholic hepatitis
Dec 01, 2008 |
not rated yet |
0
-
New insights into treatment options for patients suffering from severe alcoholic hepatitis
Apr 16, 2010 |
not rated yet |
0
-
Alcoholic liver disease is more aggressive than other chronic liver diseases
Aug 24, 2010 |
not rated yet |
0
-
Medication effective for acute liver failure in early stages of disease
Oct 08, 2009 |
not rated yet |
0
-
Alcoholics beware -- genetic variation linked to liver cirrhosis in Caucasians
Dec 16, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Flesh-Eating bacteria no cause for panic, experts say
(HealthDay) -- Despite scary headlines by the score, most people don't have to fear that they'll be the next victim of the so-called flesh-eating bacteria disease, experts say.
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
0
World Health Assembly endorses new plan to increase global access to vaccines
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to ...
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
0
Physicians definitively links irritable bowel syndrome and bacteria in gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold ...
Diseases, Conditions, Syndromes
May 25, 2012 |
not rated yet |
0
|
Study provides compelling evidence for an effective new treatment for tinnitus
According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...
Diseases, Conditions, Syndromes
May 24, 2012 |
not rated yet |
0
Infections may be deadly for many dialysis patients
An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings sugges ...
Diseases, Conditions, Syndromes
May 24, 2012 |
not rated yet |
0
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Nov 10, 2011
Rank: not rated yet
"On the basis of these presentations, it is concluded that heavy alcohol intake can result in increased accumulation of iron in the liver, in both hepatocytes and Kupffer cells"
Hepatitis has been treated by iron reduction therapy when other treatments have failed.
"Long-term phlebotomy effectively exceeds that spontaneously occurring in patients IBT-NR confirming the efficacy of iron depletion in attenuating CHC progression when other therapies have failed"
Would iron reduction therapy be an IMMEDIATE avenue to investigate due to the life shortening nature of this disease ? Iron reduction therapy has led to a reduction of death rate to zero as opposed to fifty-five percent without iron reduction therapy.
"Hypervolemic patients that were followed for a median duration of 719 days, the death rate was almost 55% vs. 0% for
those patients who were normovolemic to slightly hypovolemic"